[1-(3,4-dimethyl-2-phenyl-2H-pyrazolo[3,4-d]pyridazin-7-yl)piperidin-3-yl](1,4-dioxa-8-azaspiro[4.5]decan-8-yl)methanone
Chemical Structure Depiction of
[1-(3,4-dimethyl-2-phenyl-2H-pyrazolo[3,4-d]pyridazin-7-yl)piperidin-3-yl](1,4-dioxa-8-azaspiro[4.5]decan-8-yl)methanone
[1-(3,4-dimethyl-2-phenyl-2H-pyrazolo[3,4-d]pyridazin-7-yl)piperidin-3-yl](1,4-dioxa-8-azaspiro[4.5]decan-8-yl)methanone
Compound characteristics
| Compound ID: | E859-1721 |
| Compound Name: | [1-(3,4-dimethyl-2-phenyl-2H-pyrazolo[3,4-d]pyridazin-7-yl)piperidin-3-yl](1,4-dioxa-8-azaspiro[4.5]decan-8-yl)methanone |
| Molecular Weight: | 476.58 |
| Molecular Formula: | C26 H32 N6 O3 |
| Smiles: | Cc1c2c(c(nn1)N1CCCC(C1)C(N1CCC3(CC1)OCCO3)=O)nn(c1ccccc1)c2C |
| Stereo: | RACEMIC MIXTURE |
| logP: | 1.9352 |
| logD: | 1.9167 |
| logSw: | -2.2074 |
| Hydrogen bond acceptors count: | 7 |
| Polar surface area: | 71.289 |
| InChI Key: | VGALSVULLBOAPL-FQEVSTJZSA-N |